EANS-News: Intercell AG / Thomas Szucs elected new chairman of Intercell´s Supervisory Board

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Company Information

Wien (euro adhoc) - Vienna (Austria), December 30, 2011 - Intercell
AG (VSE, "ICLL") today announced that Thomas Szucs has been elected
chairman of Intercell´s Supervisory Board. He takes over the function
from Michel Gréco, who resigned from the role but still remains a
member of the Supervisory Board.

The new chairman Thomas Szucs has served as a member of Intercell´s
Supervisory Board since June 2011. He gained extensive experience in
the pharmaceutical and healthcare sector through several previous
positions in acknowledged organizations and companies. In his new
role he will work with the other Supervisory Board members to support
the company in its business and scientific strategic planning.

"The election to chairman is a great honor for me. I am looking
forward to working on the future success of the company, together
with my fellow Supervisory Board colleagues and the Management of
Intercell. I want to thank Michel Gréco for his great achievements in
building this exciting company", stated Thomas Szucs.

The Supervisory Board of Intercell now includes the following
members: Thomas Szucs (Chairman), Ernst-Günter Afting
(Vice-chairman), Michel Gréco, Alexander von Gabain, James Sulat and
Hans Wigzell.

The Board of Directors would like to take this opportunity to thank
Michel Gréco, who chaired Intercell´s Supervisory Board for more than
five years, for his dedication and commitment to the company.

"It has been a privilege to work with my fellow Supervisory Board
members and with an outstanding group of professionals in the
Management Board. I trust that Thomas Szucs will lead the company
into a new era of success", says Michel Gréco.

Further inquiry note:
Intercell AG
Nina Waibel
Corporate Communications
Tel. +43 1 20620-1222
communications@intercell.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

company: Intercell AG
Campus Vienna Biocenter 3
A-1030 Wien
phone: +43 1 20620-0
FAX: +43 1 20620-800
mail: investors@intercell.com
WWW: www.intercell.com
sector: Biotechnology
ISIN: AT0000612601
indexes: ATX Prime
stockmarkets: official market: Wien
language: English